Search research articles
Contact Us
Filters
Showing results (491-500 of 512) with videos related to
Page
of 52
Sort By:
Neurology
|
February 28, 2020
Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?
Alberto J Espay, Lorraine V Kalia, Ziv Gan-Or, et al.
Cancer
|
May 6, 2021
Oncologic outcomes of human papillomavirus-associated oropharynx carcinoma treated with surgery alone: A 12-institution study of 344 patients
William R Ryan, Mary J Xu, Edgar Ochoa, et al.
Annals of Neurology
|
November 20, 2018
Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke
Patrick Lyden, Kent E Pryor, Christopher S Coffey, et al.
The Lancet. Neurology
|
April 14, 2023
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
Andrew Siderowf, Luis Concha-Marambio, David-Erick Lafontant, et al.
Neurology
|
December 3, 2021
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study
Richard J Nowak, Christopher S Coffey, Jonathan M Goldstein, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 28, 2026
Clinical and Imaging Characteristics of Parkinson's Disease with Negative Alpha-Synuclein Seed Amplification Assay
Sarah M Brooker, Jacopo Pasquini, Seung Ho Choi, et al.
BMC Pregnancy and Childbirth
|
September 23, 2015
Count every newborn; a measurement improvement roadmap for coverage data
Sarah G Moxon, Harriet Ruysen, Kate J Kerber, et al.
Journal of Neuropathology and Experimental Neurology
|
August 15, 2018
Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)
Thomas G Beach, Geidy E Serrano, Thomas Kremer, et al.
Neuro-Oncology Advances
|
January 28, 2022
Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial
Corinne E Griguer, Claudia R Oliva, Christopher S Coffey, et al.
JCO Oncology Practice
|
December 4, 2025
Evolving Use of Circulating Tumor DNA for HPV+ Oropharyngeal Carcinoma: Consensus Recommendations From the California Head and Neck Consortium
Allen S Ho, Justin T Moyers, Shirin Attarian, et al.
Page
of 52
Search research articles
Search
Showing results (491-500 of 512) with videos related to
Sort By:
Page
of 52
Neurology
|
February 28, 2020
Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?
Alberto J Espay, Lorraine V Kalia, Ziv Gan-Or, et al.
Cancer
|
May 6, 2021
Oncologic outcomes of human papillomavirus-associated oropharynx carcinoma treated with surgery alone: A 12-institution study of 344 patients
William R Ryan, Mary J Xu, Edgar Ochoa, et al.
Annals of Neurology
|
November 20, 2018
Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke
Patrick Lyden, Kent E Pryor, Christopher S Coffey, et al.
The Lancet. Neurology
|
April 14, 2023
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
Andrew Siderowf, Luis Concha-Marambio, David-Erick Lafontant, et al.
Neurology
|
December 3, 2021
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study
Richard J Nowak, Christopher S Coffey, Jonathan M Goldstein, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 28, 2026
Clinical and Imaging Characteristics of Parkinson's Disease with Negative Alpha-Synuclein Seed Amplification Assay
Sarah M Brooker, Jacopo Pasquini, Seung Ho Choi, et al.
BMC Pregnancy and Childbirth
|
September 23, 2015
Count every newborn; a measurement improvement roadmap for coverage data
Sarah G Moxon, Harriet Ruysen, Kate J Kerber, et al.
Journal of Neuropathology and Experimental Neurology
|
August 15, 2018
Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)
Thomas G Beach, Geidy E Serrano, Thomas Kremer, et al.
Neuro-Oncology Advances
|
January 28, 2022
Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial
Corinne E Griguer, Claudia R Oliva, Christopher S Coffey, et al.
JCO Oncology Practice
|
December 4, 2025
Evolving Use of Circulating Tumor DNA for HPV+ Oropharyngeal Carcinoma: Consensus Recommendations From the California Head and Neck Consortium
Allen S Ho, Justin T Moyers, Shirin Attarian, et al.
Page
of 52